MDLinx6 Questions to Ask Before You Inherit an Adult ADHD Stimulant Prescription

🎓 Expert Commentary / Peer Perspective

As psychiatric access remains limited, more adult ADHD stimulant prescribing has shifted into primary care. The article outlines six documentation, safety, and monitoring questions clinicians should review before assuming responsibility for an existing stimulant prescription.

What’s at Stake

• Adult ADHD shares symptoms with anxiety, depression, PTSD, sleep disorders, and substance use disorders, complicating diagnostic certainty.
• Stimulant prescribing has increased among adults while medication shortages affect prescription access and continuity of care.
• Inadequate documentation may create challenges around diagnosis, controlled-substance monitoring, and ongoing prescribing decisions.
• Cardiovascular risk assessment, pregnancy counseling, and treatment-goal clarification may be overlooked during care transitions.

What to Watch

• Track whether prior ADHD diagnoses are supported by validated assessments and documented impairment.
• Follow monitoring safeguards including PDMP review, refill policies, and controlled-substance agreements.
• Observe how ongoing stimulant shortages affect treatment continuity and medication-switch decisions.
• Note discussions distinguishing treatment of functional impairment from potential performance-enhancement prescribing.